“drugs” Archives

in
Entry Author Date Location
Austin Biotech Xeris Names Edick CEO, Raises $41M in Series C Round 01/10/17 Texas
CEO Kaye Details Insurance Battle As Sarepta Launches Duchenne Drug 01/10/17 Boston
Merrimack Hits Reset Button, Sells Cancer Drugs to Ipsen For $575M 01/08/17 Boston
Families Fret As Insurers Mull Biogen’s $750K Spine Disease Drug 01/06/17 National
RaNA Expands, Joins Messenger RNA Drug Race With Shire Deal 01/04/17 Boston
Inotek’s Glaucoma Drug Flunks in First Phase 3 Test, Shares Crumble 01/03/17 Boston
Watching for NIH Innovation in 2017—and Drug Pricing, Trade Deals 01/02/17 San Diego
Biogen Sets $750,000 Initial Price For First-Ever Spinal Atrophy Drug 12/28/16 Boston
Texas Roundup: “1st & Future,” “Pink Tank” Pitch Contests, & More 12/23/16 Texas
Akebia Gets $265M From Otsuka to Bankroll Anemia Drug Push 12/20/16 Boston
Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug 12/19/16 Boulder/Denver
After Setback, Ophthotech Restructures, Dials Down Eye Drug Studies 12/16/16 New York
After FDA Hold, Agios Quickly Scraps One Anemia Drug, Turns to Another 12/15/16 Boston
Tour of Texas: Technium, Vapogenix, StemBioSys, & OneTeam Collective 12/12/16 Texas
Ophthotech Eye Drug Fails Badly in Pivotal Test, Shares Crumble 12/12/16 New York
Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song” 12/09/16 Indiana
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Connect Hands Out 10 Most Innovative New Product Awards 12/02/16 San Diego
Goldman Funnels $51M Into Cloud Tech Company That Fights Fake Drugs 11/30/16 Boston
Tetra Discovery Raises $10M Series A, Advances Alzheimer’s Drug 11/30/16 Detroit Ann Arbor
Amicus Shares Fall On Another Bump in Rough Road To U.S. Fabry Nod 11/28/16 New York
Amyloid Hypothesis Takes a Hit As Lilly’s Alzheimer’s Drug Fails Again 11/23/16 Indiana
Sluggish Year for IPOs, But Signs Abound of Post-Election Surge 11/22/16 National
Acorda Leans on Parkinson’s Drugs After Post-Stroke Study Fails 11/21/16 New York
Regeneron: It’s Still Wait Until 2017 For Big Heart Drug Study 11/17/16 New York
How to Lower Drug Prices, Improve Care, and Save Pharma 11/17/16 San Diego
Keeping Lead in Migraine Drug Race, Amgen Touts Data, Preps FDA Filing 11/16/16 San Francisco
With New Data, Medicines Co. Takes Long-Lasting Heart Drug to Phase 3 11/15/16 New York
Corbus Shares Climb on Early Data For Inflammation Drug 11/14/16 Boston
New Data Show Biogen, Ionis Drug Might Help More With Rare Spine Disease 11/07/16 Boston
Page 2 of 93 « previous page · next page »